Open AccessThe use of mebikar in the acute period of myocardial infarction
Author(s) -
T. S. Tagirova
Publication year - 1984
Publication title -
kazanskij medicinskij žurnal
Language(s) - English
Resource type - Journals
eISSN - 2587-9359
pISSN - 0368-4814
DOI - 10.17816/kazmj88728
Subject(s) - medicine , anesthesia , narcotic , pulmonary edema , myocardial infarction , acute pulmonary edema , depression (economics) , cardiology , lung , macroeconomics , economics
The primary task in the acute period of myocardial infarction is early and complete anesthesia, which not only relieves the suffering of the patient, but also prevents the development of reflex collapse, early arrhythmias, pulmonary edema. However, an adequate remedy has not yet been found that would have a strong analgesic effect and at the same time would not depress the cardiac and respiratory systems. Narcotic and non-narcotic analgesics, currently used to relieve pain, lead to complete anesthesia only in 15-30% of cases, to incomplete in 40 60% [3, 5]. In addition, they are characterized by undesirable side effects: depression of the respiratory center, a drop in blood pressure, a decrease in pulse [3, 4, 6]. All of the above prompts further searches for painkillers.